Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development and progression.
• Colon cancer (CC) is a significant health concern, necessitating improved prognostic markers.
• Understanding circRNA expression patterns in CC can offer new insights into tumor biology.

Purpose of the Study:

• To identify and characterize circRNAs in early-stage colon tumors.
• To investigate the association between circRNA expression and clinical outcomes, including relapse and tumor characteristics.
• To explore the potential of circRNAs as prognostic biomarkers for colon cancer.

Main Methods:

• RNA sequencing (RNAseq) was used to identify circRNAs in 181 chemonaive stage I/II colon tumors.
• Statistical analyses, including multiple correspondence analysis and Cox regression, were employed to assess associations.
• Sanger sequencing was used for validation of specific circular junctions.

Main Results:

• A comprehensive catalog of 2606 unique circRNAs was identified.
• High circRNA diversity was significantly associated with favorable disease-free survival (DFS) (HR 0.60, p=0.036).
• Specific circRNAs (circMGA, circSATB2, circNAB1, circCEP192) showed associations with relapse, microsatellite instability (MSI), and consensus molecular subtypes (CMS).

Conclusions:

• CircRNAs hold significant potential for prognostic stratification in stage I-II colon cancer patients.
• Increased circRNA diversity is a promising indicator of favorable disease-free survival.
• Further research into circRNA biomarkers could enhance clinical decision-making in colon cancer management.